4th Nov 2013 10:54
LONDON (Alliance News) - Biology company Physiomics PLC Monday said a presentation being given this week at a cancer conference is showing that the company's virtual tumour clinical programme correctly ranked different clinical regimens from literature.
Its part of the ongoing development of the platform.
The company's shares were down 2.7% at 0.18 pence Monday morning.
By Steve McGrath; [email protected]; @SteveMcGrath1
Copyright © 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
Physiomics